Eurand to Present at Bank of America Merrill Lynch Specialty Pharmaceuticals Conference
29 Julho 2010 - 9:30AM
Marketwired
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical
company, announced today that John Fraher, Chief Commercial
Officer, is scheduled to present at the Bank of America Merrill
Lynch Specialty Pharmaceuticals Conference. Details are as follows:
Date: Thursday, August 12, 2010
Time: 1:00 p.m. ET
Place: Southampton Inn
Southampton, N.Y.
A live audio webcast of the presentation can be accessed in the
investor relations section of Eurand's web site at www.eurand.com
and will be available via replay for 30 days.
About Eurand
Eurand is a specialty pharmaceutical company that develops,
manufactures and commercializes enhanced pharmaceutical and
biopharmaceutical products based on its proprietary pharmaceutical
technologies. Eurand has had six products approved by the FDA since
2001 and has a pipeline of product candidates in development for
itself and its collaboration partners. Its technology platforms
include bioavailability enhancement of poorly soluble drugs, custom
release profiles and taste-masking orally disintegrating tablet
(ODT) formulations. Eurand is a global company with facilities in
the U.S. and Europe. For more information, visit
www.eurand.com.
Contacts: Bill Newbould Vice President, Investor
Relations Eurand N.V. +1 267-759-9335 Email Contact Nick
Laudico/Sara Pellegrino The Ruth Group +1 646-536-7030/7002 Email
Contact Email Contact
Eurand N.V. (MM) (NASDAQ:EURX)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Eurand N.V. (MM) (NASDAQ:EURX)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024
Notícias em tempo-real sobre Eurand N.V. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Eurand N.V.